| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |